At Holdings Channel, we have reviewed the latest batch of the 42 most recent 13F filings for the 12/31/2024 reporting period, and noticed that Novartis (Symbol: NVS) was held by 16 of these funds.
Novartis (NVS) announced that oral Fabhalta, iptacopan, has received U.S. Food and Drug Administration approval for the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback